Go to Page # Page of 3
loading

Atosiban

 Atosiban
  9th-Oct-2018
Description: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%.
Important Tags: Atosiban
Views: 2040
Domain: Business
Category: Companies

Recent Presentations

Leadership & Management Track - Your Career!

This introduction present features on MSC business organization, initiative, and their methodologies and individual name Catherine Lewis (current L&M understudy) sharing her experi

Corine Boon PhD
18 June, 2019
...
17 June, 2019

SPIE 2019 Investor Day

SPIE today - the autonomous European pioneer in multi-specialized administrations are making specialized answers for an increasingly practical world and serving four vital markets.

...
15 June, 2019